Capital Gp VIII Llc Orbimed serves as Executive at Sionna Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Capital Gp VIII Llc Orbimed has executed 4 insider transactions totaling $1.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 24, 2025 involved selling 33,356 shares valued at $1.5M.
Capital Gp VIII Llc Orbimed currently holds 3,561,655 shares of Sionna Therapeutics, Inc. (SION), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Gp VIII Llc Orbimed has been a net seller of SION stock. They have purchased $0 and sold $1.6M worth of shares.
Capital Gp VIII Llc Orbimed's most recent insider trade was on Dec 24, 2025, when they sold 33,356 shares at $44.55 per share.
Get notified when new Form 4 filings are submitted
| $44.49 |
| Discretionary |
| Dec 18, 2025 | SION | $4.4K | Sale | 100 | $44.49 | Discretionary |
| Dec 17, 2025 | SION | $40.0K | Sale | 900 | $44.50 | Discretionary |